Literature DB >> 24821721

Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils.

Keiko Ueno-Shuto1, Kosuke Kato2, Yukihiro Tasaki3, Miki Sato3, Keizo Sato4, Yuji Uchida5, Hiromichi Sakai3, Tomomi Ono3, Mary Ann Suico3, Kazunori Mitsutake3, Naofumi Tokutomi5, Hirofumi Kai3, Tsuyoshi Shuto6.   

Abstract

Single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) is one of the immunoglobulin-like membrane proteins that is crucial for negative regulation of toll-like receptor 4 (TLR4) and interleukin-1 receptor. Despite the importance of understanding its expression and function, knowledge is limited on the regulatory mechanism in the epithelial tissues, such as the liver, lung, and gut, where its predominant expression is originally described. Here, we found expression of SIGIRR in non-epithelial innate immune cells, including primary peripheral blood monocytes, polymorphonuclear neutrophils, monocytic RAW264 cells, and neutrophilic-differentiated HL-60 cells. Consistent with previous findings in epithelial tissues, SIGIRR gene and protein expression were also down-regulated by LPS treatment in a time-dependent manner in primary blood monocytes and polymorphonuclear neutrophils. A reduction was also observed in RAW264 and differentiated HL-60 cells. Notably, exogenous introduction of the dominant negative form of TLR4 and siRNA of p38 resulted in inhibition of LPS-induced SIGIRR down-regulation, whereas treatment with p38 activator anisomycin showed a dose-dependent decrease in SIGIRR expression, suggesting TLR4-p38 signal as a critical pathway for LPS-induced SIGIRR down-regulation. Finally, reporter gene and chromatin immunoprecipitation assays demonstrated that Sp1 is a key factor that directly binds to the proximal promoter of SIGIRR gene and consequently regulates basal SIGIRR expression, which is negatively regulated by the LPS-dependent TLR4-p38 pathway. In summary, the data precisely demonstrate how LPS down-regulates SIGIRR expression and provide a role of LPS signal that counteracts Sp1-dependent basal promoter activation of SIGIRR gene via TLR4-p38 pathway in non-epithelial innate immune cells.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Gene Expression; Lipopolysaccharide (LPS); Monocyte; Neurotrophin; Promoter; Single Immunoglobulin IL-1R-related Molecule (SIGIRR); Specificity Protein 1 (Sp1); Toll-like Receptor (TLR); p38

Mesh:

Substances:

Year:  2014        PMID: 24821721      PMCID: PMC4140261          DOI: 10.1074/jbc.M113.532093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

Authors:  David Wald; Jinzhong Qin; Zhendong Zhao; Youcun Qian; Mayumi Naramura; Liping Tian; Jennifer Towne; John E Sims; George R Stark; Xiaoxia Li
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

Review 2.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

3.  Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily.

Authors:  E Thomassen; B R Renshaw; J E Sims
Journal:  Cytokine       Date:  1999-06       Impact factor: 3.861

4.  Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction.

Authors:  C A Hazzalin; R Le Panse; E Cano; L C Mahadevan
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.

Authors:  Katarzyna Bulek; Shadi Swaidani; Jinzhong Qin; Yi Lu; Muhammet F Gulen; Tomasz Herjan; Booki Min; Robert A Kastelein; Mark Aronica; Magdalena Kosz-Vnenchak; Xiaoxia Li
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.

Authors:  Elizabeth K Brint; Damo Xu; Haiying Liu; Aisling Dunne; Andrew N J McKenzie; Luke A J O'Neill; Foo Y Liew
Journal:  Nat Immunol       Date:  2004-03-07       Impact factor: 25.606

7.  MUC1 mucin is a negative regulator of toll-like receptor signaling.

Authors:  Keiko Ueno; Takeshi Koga; Kosuke Kato; Douglas T Golenbock; Sandra J Gendler; Hirofumi Kai; K Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-13       Impact factor: 6.914

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells.

Authors:  Tsuyoshi Shuto; Takashi Furuta; Judy Cheung; Dieter C Gruenert; Yuko Ohira; Shogo Shimasaki; Mary Ann Suico; Keizo Sato; Hirofumi Kai
Journal:  Leuk Res       Date:  2007-07-30       Impact factor: 3.156

Review 10.  The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

Authors:  Luke A J O'Neill
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

View more
  13 in total

1.  A novel role for myeloid cell-specific neuropilin 1 in mitigating sepsis.

Authors:  Xiaoyan Dai; Imoh Okon; Zhaoyu Liu; Yue Wu; Huaiping Zhu; Ping Song; Ming-Hui Zou
Journal:  FASEB J       Date:  2017-03-21       Impact factor: 5.191

2.  IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy.

Authors:  Federica Riva; Laura Bianchessi; Camilla Recordati; Alessia Inglesi; Vittoria Castiglioni; Lauretta Turin
Journal:  Vet Sci       Date:  2022-06-14

Review 3.  MMP-9 signaling in the left ventricle following myocardial infarction.

Authors:  Rugmani Padmanabhan Iyer; Mira Jung; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

4.  Pharmacological and genetic reappraisals of protease and oxidative stress pathways in a mouse model of obstructive lung diseases.

Authors:  Tsuyoshi Shuto; Shunsuke Kamei; Hirofumi Nohara; Haruka Fujikawa; Yukihiro Tasaki; Takuya Sugahara; Tomomi Ono; Chizuru Matsumoto; Yuki Sakaguchi; Kasumi Maruta; Ryunosuke Nakashima; Taisei Kawakami; Mary Ann Suico; Yoshitaka Kondo; Akihito Ishigami; Toru Takeo; Ken-Ichiro Tanaka; Hiroshi Watanabe; Naomi Nakagata; Kohei Uchimura; Kenichiro Kitamura; Jian-Dong Li; Hirofumi Kai
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

5.  Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.

Authors:  Yan Li; Wei Zhang; Jianxin Gao; Jiaqi Liu; Hongtao Wang; Jun Li; Xuekang Yang; Ting He; Hao Guan; Zhao Zheng; Shichao Han; Maolong Dong; Juntao Han; Jihong Shi; Dahai Hu
Journal:  Stem Cell Res Ther       Date:  2016-08-02       Impact factor: 6.832

6.  The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation.

Authors:  Lian Li; Jianxin Wei; Shuang Li; Anastasia M Jacko; Nathaniel M Weathington; Rama K Mallampalli; Jing Zhao; Yutong Zhao
Journal:  EBioMedicine       Date:  2019-06-14       Impact factor: 8.143

7.  Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.

Authors:  Raffaella Bonecchi; Cecilia Garlanda; Alberto Mantovani; Federica Riva
Journal:  Cytokine       Date:  2016-08-04       Impact factor: 3.861

Review 8.  Regulatory Role of IL-1R8 in Immunity and Disease.

Authors:  Martina Molgora; Isabella Barajon; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2016-04-20       Impact factor: 7.561

9.  IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.

Authors:  Dimity H Ball; Lamyaa Al-Riyami; William Harnett; Margaret M Harnett
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.